November 15, 2013, Waltham, Mass., USA - BG Medicine, Inc., a life sciences company, announced that it has appointed Stephen P. Hall as the company's executive vice president, chief financial officer.<br /><br />Mr. Hall most recently held the position of Vice President Finance — Treasurer, Principal Financial and Chief Accounting Officer at Stemline Therapeutics, a publicly traded clinical stage biopharmaceutical company.<br /><br />Prior to joining Stemline Therapeutics, Mr. Hall served as Chief Financial Officer at both life science and medical device companies, including Orthocon, Inc., Helicos BioSciences Corporation, TriPath Imaging, Inc., and Colorado MEDtech.<br /><br />Mr. Hall, a certified public accountant, began his professional career with Peat, Marwick, Mitchell & Co., in Chicago, IL. In addition to his experience as an operating CFO, he spent nearly 10 years in commercial banking.<br /><br />He received his AB degree from Harvard College and MBA from Stanford University Graduate School of Business. Mr. Hall will replace Charles Abdalian, who has served as BG Medicine's CFO since October 2012. 